PubMed Health⌕ Search

PubMed · 7272415

Matching in epidemiologic studies: validity and efficiency considerations.

Abstract

Validity and efficiency issues are considered with regard to the use of matching and random sampling as alternative methods of subject selection in follow-up and case-control studies. We discuss the simple situation involving dichotomous disease and exposure variables and a single dichotomous matching factor, and we consider the influence on efficiency of a possible loss of subjects due to matching constraints. The decision to match or not should be motivated by efficiency considerations. An efficiency criterion based on a comparison of confidence intervals under matching and random sampling for the effect measure of interest (the risk ratio and risk difference in follow-up studies, and the odds ratio in case-control studies) leads to the following conclusions when the sampling method does not influence the size of the comparison group. In follow-up studies, matching on a confounder is expected to lead to a gain in efficiency over random sampling, while matching on a nonconfounder is not expected to result in a loss of efficiency. In case-control studies, the same conclusions hold, except that matching is not as advantageous as in follow-up studies and can lead to a loss of efficiency in some situations (usually of little practical importance). When matching reduces the size of the comparison group, there is likely to be a meaningful gain in efficiency due to random sampling only when the matched comparison group is at most 40-50% the size of the randomly-sampled comparison group is a follow-up study, and at most 50-65% the size in a case-control study.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

L L Kupper, J M Karon, D G Kleinbaum, H Morgenstern, D K Lewis. 1981. Matching in epidemiologic studies: validity and efficiency considerations.. https://pubmed.ncbi.nlm.nih.gov/7272415/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Laparoscopic gastrectomy with regional lymph node dissection for upper gastric cancer.

BACKGROUND: The technique and results of laparoscopic gastrectomy in 110 patients with gastric cancer located in the upper third of the stomach are presented. METHODS: Proximal gastrectomy was performed for lesions in the upper third of the stomach, and total gastrectomy for those that spread over both the upper and middle third. D1 and D2 lymph node dissection was undertaken in patients with T1 or T2 lesions. Anastomosis of the oesophagus was performed intracorporeally using a conventional circular stapling device or a laparoscopic linear stapler. RESULTS: Median operating time was 247 min for proximal gastrectomy and 285 min for total gastrectomy; median blood loss was 207 and 334 ml respectively. A median of 23 lymph nodes was harvested from patients in the proximal gastrectomy group and 34 from those having a total gastrectomy. There was minimal morbidity and fast recovery after surgery. Postoperative recurrence occurred in only one patient, giving a recurrence rate of 0.9 per cent. CONCLUSION: Laparoscopic gastrectomy for upper gastric cancer appears to be a safe and curative procedure.

Follow-Up Studies↗

Pyloroplasty with fundoplication in the treatment of combined gastroesophageal reflux disease and bloating.

BACKGROUND: Although gastroparesis does not influence gastroesophageal reflux disease (GERD) or antireflux surgery, many patients with GERD will also suffer from gastroparesis-related bloating as a distinct symptom different from GERD-related symptoms. The purpose of this study was to assess whether a pyloroplasty with a fundoplication will improve bloating symptoms in these patients. METHODS: A prospectively gathered database of all patients undergoing antireflux surgery was reviewed. All patients underwent history, physical examination, upper gastrointestinal endoscopy, esophageal manometry, 24-hour esophageal pH monitoring, and, selectively, contrast upper gastrointestinal radiography. Patients with symptoms of bloating also underwent gastric emptying scintigraphy. All patients completed the GERD-Health Related Quality of Life (HRQL) symptom severity questionnaire. One of the items of this instrument relates to bloating. The item is scored from 0 (asymptomatic) to 5 (incapacitating) based on descriptive anchors. Patients with symptomatic GERD and objective findings by physiologic testing were offered antireflux surgery. Those with delayed gastric emptying (defined as T(1/2) > 120 minutes) were also offered a pyloroplasty. Operations performed included a laparoscopic or open Nissen or Toupet fundoplication with a Heineke-Mickulicz pyloroplasty. Postoperatively, patients completed the GERD-HRQL and had a gastric emptying scintigraphy performed. RESULTS: Three-hundred and sixty-nine patients underwent antireflux surgery; of these, 35 patients also had a pyloroplasty. Twenty-eight (80%) of these patients reported significant symptomatic improvement. The median preoperative bloating score improved from 4 to 1 postoperatively (P < 0.05), and the median gastric emptying scintigraphy T(1/2) improved from 244 to 112 minutes (P < 0.05). CONCLUSIONS: Although gastroparesis may not contribute to symptoms of GERD, it can contribute to symptoms of bloating. Bloating symptoms improved in 80% of patients with the addition of a pyloroplasty. Therefore, addition of pyloroplasty to a fundoplication in patients with gastroparesis-related bloating can improve bloating symptoms.

Follow-Up Studies↗